Kent Rogers Email & Phone Number

Irvine, Ca, Us

Irvine, Ca, Us

Boston, Ma, Us

Chicago, Il, Us

For over 30 years, ARCH has backed disruptive science companies with as little as $50K to as much as hundreds of millions of dollars, per company. We are committed to building innovative companies that impact and improve human health and take a long-term view when building companies. The firm is a recognized leader in commercializing technologies developed at academic institutions, corporate research groups and national laboratories. We invest primarily in companies we co-found with leading scientists and entrepreneurs, bringing innovations in life sciences and physical sciences to market.

Responsible for the build and operations of all strategic commercialization functions for pipeline assets in oncology and immunology disease states including; marketing, sales, product distribution, commercial operations, payer strategy and payer/provider contracted partnerships (US and ex-US – emphasis in the EU). The commercial model was non-traditional with an emphasis on Payer/Provider partnership agreements and digital marketing strategies to drive market adoption vs. investment in traditional, large field-based commercial functions. We successfully secured unique contract agreements with payers inclusive of the VHA, national PBMs, and regional payers which required the payers to pull through market adoption for hundreds of millions of insured lives in the US.

Eden Prairie , Mn, Us

SVP, Chief Industry Relations Officer for OptumRx, a division of Optum under the United Health Group enterprise. Had leadership over the Commercial & Medicare formulary contracting strategy for all books of business, Optum Specialty & Infusion contracting strategies, and client services strategies which include FFS Medicaid and a Formulary Consulting Group. Responsible for over $16B in Specialty drug procurement and over $95B in annual drug spend for all books of internal and external business with United Health Group’s United Healthcare and OptumRx PBM operations.

Philadelphia, Pa, Us

Blue Fin Group is a professional consulting firm with mature project and engagement skills and methodologies working for a wide array of branded pharmaceuticals, biotech, generics, consumer health, and medical device manufacturers in the area of sales and marketing product program management. Deep experience and proven success assessing and developing strategies for manufacturers across a broad range of company size, portfolios, and lifecycles.Blue Fin provides tailored intelligence on the healthcare industry. We conduct seminars, summits, environmental scans, articles and white papers, full training sessions, and custom research efforts with read-outs. Blue Fin conducts two independent types (or phases) of consulting projects: strategy development and implementation. In the strategy development phase, our goal is a high-level business case and strategic roadmap that informs a team what is being done, why, how long it takes, what it costs and who is responsible for it. In the implementation phase, the end goal is the deployment of the solution.

Pearl River, New York, Us

Led the development and deployment of the first Managed Markets department in company history which included; field-based account managers, field-based reimbursement specialists, field-based Directors, and home-office based personnel (Payer Strategy, Trade/Channel Strategy, Contracting/Pricing) to support all activities related to reimbursement for pipeline and in-licensed promoted products. Oversaw P&L which included all costs associated with direct reports, as well as, budget spend on a Patient Support Services HUB, Co-Pay Mitigation Programs, Patient Assistance Programs and third-party logistics product distribution (3PL). Served on the Executive Steering Committee for the Acorda Mentorship Program, the Business Development Advisory Counsel in all matters associated with prospective product in-licensing, acquisition, or co-promotion, the Joint Commercial Committee as part of an international marketing agreement with Biogen-Idec, Inc, and the Quality Review Committee – a committee of VPs from multiple departments responsible for oversight of pharmacovigilence, adverse event reporting, and adherence to FDA REMS reporting requirements.

Rahway, New Jersey, Us

Led and managed a team responsible for the development and implementation of marketing strategies to support over 100 field based account managers in therapy areas of cardiovascular disease, CNS, Oncology and Hepatitis C. Managed all aspects of promotional materials and marketing programs through a legal and regulatory approval process. Served on executive team for the review and approval of contract proposals for all books of business including; commercial HMO/PBM, Medicaid, Medicare Part D, federal markets and hospital systems. Developed the U.S. pricing/reimbursement launch strategy for multiple products totaling over $15 billion in annual sales.

Kenilworth, Nj, Us

Various leadership roles as National Account Executive with Merck/Schering Plough, National Account Manager with Schering Plough, Oncology & Biotech Sales Specialist and Primary Care Sales Representative.

Mba, International Business

Bachelor Of Science (B.S.), Business Management & Organizational Change

Education record